Kaynaklar
- Meltzer HY, Young M, Metz J, Fang VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979; 45(2): 165–75.
- Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants. A review of the literature and analysis of spontaneous reports. Ann Clin Psychiatry 2010; 22(3): 148–56.
- Lambert MT, Trutia C, Petty F. Extrapyramidal adverse effects associated with sertraline. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22(5): 741–8.
- Madhusoodanan S, Brenner R. Reversible choreiform dyskinesia and extrapyramidal symptoms associated with sertraline therapy. J Clin Psychopharmacol 1997; 17(2): 138–9.
- Dale RC, Singh H, Troedson C, Pillai S, Gaikiwari S, Kozlowska K. A prospective study of acute movement disorders in children. Dev Med Child Neurol 2010; 52(8): 739–48.
- Choo V. Paroxetine and extrapyramidal reactions. Lancet 1993; 341: 624.
- Coulter DM, Pillans PI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995; 152(1): 122–25.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45.
- Tolosa ES, Marti J. Adult-onset idiopathic torsion dystonias. In Movement Disorders, Watts RL, Koller WC (editors). 2nd ed. United States: McGraw-Hill Companies; 2004.
- Tuncel D, Orhan Ö. Tek doz sertraline bağlı ortaya çıkan akut distoni olgusu. Klinik Farmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2009:19(Suppl.1): S238–S9.
- Lewis CF, DeQuardo JR, Tandon R. Dystonia associated with trazodone and sertraline. J Clin Psychopharmacol 1997; 17(1): 64–5.
- Shihabuddin L, Rapport D. Sertraline and extrapyramidal side effectts. Am J Psychiatry 1994; 151(2): 288
- Annagür BB, Tamam L. Antipsikotik kullanımına bağlı bilateral temporamandibular eklem dislokasyonu Nöropsikiyatri Arşivi-Archives of Neuropsychiatry 2010; 47(4): 351–3
- Hedenmalm K, Güzey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol 2006; 26(2): 192–7.
- Bendtsen L, Jensen R. Treating tension-type headache—an expert opinion. Expert Opin Pharmacother 2011; 12(7): 1099–109.